BioPharma Management and Consulting
0664.691.906 · rovalta.com · 23/09/2026
BioPharma Management and Consulting
Overview
What does BioPharma Management and Consulting do?
BioPharma Management and Consulting is a Private limited company incorporated in 2016. Its main activity is: Other business support service activities n.e.c.. Its registered office is in Walcourt.
5650 Walcourt · Wallonie
Trend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||
| Gross margin | 191,3 k € | -16.7% | 229,5 k € | -25.7% | 309,1 k € | -9.2% | 340,5 k € | -23.8% | 446,8 k € | -75.1% | 1,8 M € | +1562% | 108,1 k € | +6.2% | 101,8 k € | +8.3% | 94 k € | +537% | 14,7 k € |
| EBITDA | 181 k € | -15.6% | 214,4 k € | -30.4% | 308,1 k € | -9.3% | 339,6 k € | -24.0% | 446,7 k € | -75.1% | 1,8 M € | +1568% | 107,7 k € | +5.8% | 101,8 k € | +8.3% | 94 k € | +553% | 14,4 k € |
| Operating result | 59,6 k € | -36.2% | 93,4 k € | -67.0% | 283 k € | -16.7% | 339,6 k € | -23.0% | 441 k € | -75.3% | 1,8 M € | +1680% | 100,5 k € | +6.2% | 94,6 k € | +8.9% | 86,8 k € | +570% | 13 k € |
| Net result | 29 k € | -50.0% | 58 k € | -72.5% | 211 k € | -17.4% | 255,6 k € | -11.8% | 289,8 k € | -62.4% | 770,8 k € | +891% | 77,8 k € | +5.5% | 73,7 k € | +25.6% | 58,7 k € | +524% | 9,4 k € |
| Balance sheet | |||||||||||||||||||
| Equity | 18,6 k € | -44.4% | 33,5 k € | +63.6% | 20,5 k € | 0.0% | 20,5 k € | 0.0% | 20,5 k € | 0.0% | 20,5 k € | 0.0% | 20,5 k € | -86.7% | 154,2 k € | +91.6% | 80,5 k € | +269% | 21,8 k € |
| Total assets | 3,2 M € | -3.4% | 3,3 M € | -2.5% | 3,4 M € | +980% | 310,5 k € | -12.8% | 356 k € | -68.1% | 1,1 M € | +323% | 263,7 k € | +41.9% | 185,9 k € | +56.6% | 118,7 k € | +85.3% | 64,1 k € |
| Cash | 132,5 k € | +54.3% | 85,8 k € | -18.6% | 105,5 k € | -58.4% | 253,7 k € | +17.3% | 216,2 k € | -71.8% | 767,1 k € | +436% | 143,2 k € | +25.1% | 114,4 k € | +287% | 29,6 k € | +162% | 11,3 k € |
| Debts | 3,1 M € | -2.9% | 3,2 M € | -3.1% | 3,3 M € | +1050% | 290 k € | -13.6% | 335,6 k € | -69.4% | 1,1 M € | +350% | 243,2 k € | +668% | 31,7 k € | -17.2% | 38,2 k € | -9.5% | 42,3 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 3 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2026 | 28/02/2025 | 04/10/2024 | 29/03/2023 | 26/05/2022 | 25/05/2021 |
| General meeting | 22/06/2026 | 30/01/2025 | 04/10/2024 | 25/03/2023 | 11/05/2022 | 19/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
10 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 22/06/2026 | 23/06/2026 | French | |
| Micro model | 31/12/2024 | 30/01/2025 | 28/02/2025 | French | |
| Micro model | 31/12/2023 | 04/10/2024 | 04/10/2024 | French | |
| Micro model | 31/12/2022 | 25/03/2023 | 29/03/2023 | French | |
| Micro model | 31/12/2021 | 11/05/2022 | 26/05/2022 | French | |
| Micro model | 31/12/2020 | 19/05/2021 | 25/05/2021 | French | |
| Micro model | 31/12/2019 | 25/05/2020 | 28/05/2020 | French | |
| Micro model | 31/12/2018 | 08/10/2019 | 08/10/2019 | French | |
| Micro model | 31/12/2017 | 31/07/2018 | 31/07/2018 | French | |
| Abridged model | 31/12/2016 | 27/06/2017 | 27/06/2017 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202529 k €↓
- 2024Annual accounts 202458 k €↓
- 2023Annual accounts 2023211 k €↓
- 2023Name changeBM&C - BioPharma Consulting & Management
- 2022Annual accounts 2022255,6 k €↓
- 2022Name changeBM&C
- 2021Annual accounts 2021289,8 k €↓
- 2021Name changeBiopharma Management & Consulting
- 2020Annual accounts 2020770,8 k €↑
- 2019Annual accounts 201977,8 k €↑
- 2018Annual accounts 201873,7 k €↑
- 2017Annual accounts 201758,7 k €↑
- 2016Annual accounts 20169,4 k €
- 17/10/2016IncorporationPrivate limited company
- 2016Name changeBioPharma Management and Consulting